Search results
Results from the WOW.Com Content Network
MDAI, also known as 5,6-methylenedioxy-2-aminoindane, is an entactogen drug of the 2-aminoindane group which is related to MDMA and produces similar subjective effects. [ 4 ] [ 5 ] [ 6 ] [ 1 ] It acts as a selective serotonin and norepinephrine releasing agent (SNRA). [ 2 ]
3,4-Methylenedioxyamphetamine (MDA), sometimes referred to as “sass,” is an empathogen-entactogen, stimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug.
Structure Chemical Name Abbreviations Other Names CAS number Ref 3,4-Methylenedioxyphenethylamine: MDPEA: Homopiperonylamine: 1484-85-1: 3,4-Methylenedioxy-N-methylphenethylamine
MDAI: 114: 117: 1334 MMAI: 31: 3101 >10000 MEAI: 134: 861: 2646 Notes: The smaller the value, the more strongly the compound produces the effect. See also Monoamine releasing agent § Activity profiles for a larger table with more compounds.
Empathogens or entactogens are a class of psychoactive drugs that induce the production of experiences of emotional communion, oneness, relatedness, emotional openness—that is, empathy or sympathy—as particularly observed and reported for experiences with 3,4-methylenedioxymethamphetamine (). [1]
3,4-Methylenedioxy-N-ethylamphetamine (MDEA; also called MDE and colloquially, Eve) is an empathogenic psychoactive drug.MDEA is a substituted amphetamine and a substituted methylenedioxyphenethylamine.
3,4-Methylenedioxyphenethylamine, also known as 3,4-MDPEA, MDPEA, and homopiperonylamine, is a substituted phenethylamine formed by adding a methylenedioxy group to phenethylamine.
Homarylamine (INN; [1] also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is an antitussive (anti-cough) drug [2] which was patented in 1956 by Merck & Co., [3] but has never been used medically as such.